Catecholamines.
D000313:Adrenal Medulla / Q000378:metabolism; D000342:Affective Symptoms / Q000188:drug therapy; D000818:Animals; D001921:Brain / Q000378:metabolism; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D002395:Catecholamines / Q000096:biosynthesis / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008750:Methyldopa / Q000494:pharmacology; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009411:Nerve Endings / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy; D011955:Receptors, Drug; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism; D013566:Sympathomimetics / Q000494:pharmacology; D009435:Synaptic Transmission; D014443:Tyrosine / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D011955:Receptors, Drug; D013566:Sympathomimetics; D014443:Tyrosine; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase